CY1106450T1 - Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους - Google Patents

Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους

Info

Publication number
CY1106450T1
CY1106450T1 CY20071100207T CY071100207T CY1106450T1 CY 1106450 T1 CY1106450 T1 CY 1106450T1 CY 20071100207 T CY20071100207 T CY 20071100207T CY 071100207 T CY071100207 T CY 071100207T CY 1106450 T1 CY1106450 T1 CY 1106450T1
Authority
CY
Cyprus
Prior art keywords
derivatives
bacteriochlorofoil
palladium
ch2oh
substituted
Prior art date
Application number
CY20071100207T
Other languages
English (en)
Inventor
Avigdor Scherz
Yoram Salomon
Alexander Brandis
Hugo Scheer
Original Assignee
Yeda Research And Development Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Company, Ltd. filed Critical Yeda Research And Development Company, Ltd.
Publication of CY1106450T1 publication Critical patent/CY1106450T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Υποκατεστημένα με παλλάδιο Βακτηριοχλωροφυλλικά παράγωγα του τύπου (I), όπου το Α αντιπροσωπεύει OH, OR1, -O-(CH2)n-Y, -S-(CH2)n-Y, -NH-(CH2)n-Y, -O-(CH2)2-NH2, -O-(CH2)2-OH, -NH-(CH2)n- +N o, X-, -NH-(CH2)2-NH=BOC ή -N-(CH2-CH=CH2)2- όπου το R1 αντιπροσωπεύει Na+, K+, (Ca2+)0.5, (Mg2+)0.5, Li+, NH4+, +NH3-C(CH2OH)3, +NH3-CH2-(CHOH)4-CH2OH, +NH2(CH3)-CH2-(CHOH)4-CH2OH ή +N(Cn’H2n’+1)4˙ το R2 αντιπροσωπεύει Η, OH ή COOR4, όπου το R4 είναι C1-C12 αλκύλιο ή C3-C12 κυκλοαλκύλιο˙ το R3 αντιπροσωπεύει Η, ΟΗ ή C1-C12 αλκύλιο ή αλκοξυ˙ το n είναι 1, 2, 3, 4, 5 ή 6, το Υ είναι -NR'1R'2 ή -+NR'1R'2R'3,Χ― όπου τα R'1, R'2 και R'3 ανεξάρτητα το ένα από το άλλο αντιπροσωπεύουν -CH3 ή -C2H5˙ το Χ είναι F, CI, Br ή I, το n' είναι 1, 2, 3 ή 4 και οι οξειδωμένες τους μορφές, είναι χρήσιμα στο πεδίο της φωτοδυναμικής θεραπείας (PDT).
CY20071100207T 1998-12-09 2007-02-15 Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους CY1106450T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98403110 1998-12-09
EP99958470A EP1137411B1 (en) 1998-12-09 1999-12-09 Palladium-substituted bacteriochlorophyll derivatives and use thereof
PCT/IL1999/000673 WO2000033833A1 (en) 1998-12-09 1999-12-09 Palladium-substituted bacteriochlorophyll derivatives and use thereof

Publications (1)

Publication Number Publication Date
CY1106450T1 true CY1106450T1 (el) 2011-10-12

Family

ID=8235584

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100207T CY1106450T1 (el) 1998-12-09 2007-02-15 Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους

Country Status (22)

Country Link
US (1) US6569846B1 (el)
EP (1) EP1137411B1 (el)
JP (1) JP4796227B2 (el)
CN (1) CN1160069C (el)
AT (1) ATE347554T1 (el)
AU (1) AU771292B2 (el)
BR (1) BRPI9916096B8 (el)
CA (1) CA2353554C (el)
CY (1) CY1106450T1 (el)
DE (1) DE69934328T2 (el)
DK (1) DK1137411T3 (el)
ES (1) ES2277454T3 (el)
HK (1) HK1040638B (el)
HU (1) HU228208B1 (el)
IL (1) IL143591A0 (el)
NO (1) NO331426B1 (el)
NZ (1) NZ512093A (el)
PL (1) PL201172B1 (el)
PT (1) PT1137411E (el)
RU (1) RU2234508C2 (el)
SI (1) SI1137411T1 (el)
WO (1) WO2000033833A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
EP1318807A4 (en) * 2000-08-11 2008-02-20 Ceramoptec Gmbh LIGHT-SENSITIVE OINTMENT
EP1277470A1 (fr) * 2001-07-17 2003-01-22 Steba Biotech N.V. Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation
BR0304716A (pt) * 2002-05-08 2004-07-13 Yeda Res & Dev Método para formação de imagens de mri-bold on line, sensibilizada
JP4529344B2 (ja) * 2002-06-03 2010-08-25 ニプロ株式会社 腫瘍組織の酸素濃度を上昇させるためのポルフィリン酸素輸液製剤
EP1517684B1 (en) 2002-06-27 2009-07-22 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
AU2003249742A1 (en) * 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
KR101191700B1 (ko) * 2004-06-07 2012-10-16 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 양이온성 박테리오클로로필 유도체 및 이의 용도
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
US20110040170A1 (en) * 2008-01-28 2011-02-17 Yeda Research And Development Co., Ltd. Endoscopic imaging photodynamic therapy system and methods of use
DK2257309T3 (da) 2008-02-27 2020-01-20 Yeda Res And Development Company Ltd Rgd-(bakterie)chlorophyl-konjugater til anvendelse ved diagnose af tumorer, der omfatter nekrotiske domæner
US20120034155A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
EP2425873A1 (fr) 2010-09-07 2012-03-07 Steba Maor SA Modélisation de l'action d'une fibre optique dans un traitement par therapie photodynamique, et assistance à la planification d'un tel traitement
CN103405769A (zh) * 2013-03-07 2013-11-27 北京亿仁赛博医疗科技研发中心有限公司 光敏剂在制备治疗疾病的病毒灭活药物中的应用
DK2971026T3 (da) 2013-03-11 2021-02-15 Tookad Ip Sarl Fremgangsmåde til produktion af bakterieklorofyl a
CN105377862B (zh) 2013-03-15 2019-09-13 希瑞·安·麦克法兰 用作光动力化合物的金属基配合物及其用途
AU2017250732B2 (en) 2016-04-10 2022-11-10 Memorial Sloan-Kettering Cancer Center Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative
US10933134B2 (en) 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
AU1583400A (en) 2000-06-26
NO331426B1 (no) 2011-12-27
HUP0105411A3 (en) 2003-12-29
AU771292B2 (en) 2004-03-18
HK1040638A1 (en) 2002-06-21
EP1137411A4 (en) 2003-04-23
IL143591A0 (en) 2002-04-21
CN1160069C (zh) 2004-08-04
BR9916096A (pt) 2001-11-13
CA2353554A1 (en) 2000-06-15
HK1040638B (zh) 2007-06-15
NO20012807L (no) 2001-08-08
JP2002531497A (ja) 2002-09-24
US6569846B1 (en) 2003-05-27
WO2000033833A1 (en) 2000-06-15
CN1334728A (zh) 2002-02-06
DK1137411T3 (da) 2007-03-26
PT1137411E (pt) 2007-02-28
RU2234508C2 (ru) 2004-08-20
BR9916096B1 (pt) 2013-11-19
JP4796227B2 (ja) 2011-10-19
CA2353554C (en) 2011-04-26
HUP0105411A2 (hu) 2002-04-29
EP1137411B1 (en) 2006-12-06
NO20012807D0 (no) 2001-06-07
ATE347554T1 (de) 2006-12-15
BRPI9916096B8 (pt) 2021-05-25
SI1137411T1 (sl) 2007-10-31
PL348201A1 (en) 2002-05-06
DE69934328D1 (de) 2007-01-18
PL201172B1 (pl) 2009-03-31
EP1137411A1 (en) 2001-10-04
NZ512093A (en) 2003-04-29
ES2277454T3 (es) 2007-07-01
DE69934328T2 (de) 2007-07-19
HU228208B1 (en) 2013-01-28

Similar Documents

Publication Publication Date Title
CY1106450T1 (el) Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους
IT1294325B1 (it) Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
CY1113813T1 (el) Νεες ενωσεις που εχουν ανασταλτικη δραστικοτητα εναντια στον εξαρτωμενο απο το νατριο μεταφορεα
CY1107509T1 (el) Αμινοθειαζολες ως αναστολεις κυκλινη - εξαρτωμενων κινασεων
NL300178I2 (nl) Nieuwe peptidederivaten.
ES2174551T3 (es) Utilizacion de alcanos semifluorados como agentes dermatologicos.
CY1105948T1 (el) Παραγωγα φαινυλακεταμιδο-θειαζολης, διepγασια για την παρασκευη τους και η χρηση τους ως παραγοντων κατα των ογκων
FI845070A0 (fi) 1,3,4,5-tetrahydrobenz/c,d/indoler, deras framstaellningsfoerfarande och anvaendning.
MX25770A (es) Compuestos antidiabeticos y procedimientos para supreparacion.
DE69431316T2 (de) Amidderivate und ihre therapeutische Verwendung
NO20022976L (no) 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet
DE3686723D1 (de) Oxadiazolylacetonitrile, ihre herstellung und anwendung.
IT1140535B (it) Derivati benzoazepinici
DE3856387T2 (de) 1,2,3,4,10,14b-HEXAHYDRODIBENZO-c,f]PYRAZINO-1,2-a]AZEPINO-DERIVATE
FI973894A0 (fi) 9-substituoidut porfyseenit
FI874123A (fi) Heptanoyl-glu-asp-ala-aminosyra -immunostimulanter.
ATE189203T1 (de) Trizyklische derivate, ihre herstellung, ihre verwendung zur herstellung von optisch aktivem oder racemischem colchizin, thiocolchizin, dessen analoge oder derivate, und intermediate
FI922826A (fi) Piperidinfoereningar och farmaceutisk komposition.
DE3769333D1 (de) Acylaminomethylimidazo(1,2-a)pyrimidinderivate, ihre herstellung und therapeutische verwendung.
MX9204194A (es) Los compuestos de 1,2,4-oxadiazolil-fenoxialquilisoxazolas y su uso como agentes antivirales
ATE157539T1 (de) 3-benzoyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen mit anti-arrhythmischer wirkung
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
DE3864428D1 (de) Haarfaerbemittel mit direktziehenden nitrodiphenylamin-derivaten.
RU2001128443A (ru) Способ передачи энергоинформационных характеристик лекарственных средств
ES8701179A1 (es) Procedimiento para la obtencion de hidrazino y amino pirida-zino (4,5b) indoles